S-1 EX-FILING FEES 0001402328 N/A N/A 0001402328 1 2026-10-01 2026-10-01 0001402328 2 2026-10-01 2026-10-01 0001402328 3 2026-10-01 2026-10-01 0001402328 4 2026-10-01 2026-10-01 0001402328 5 2026-10-01 2026-10-01 0001402328 6 2026-10-01 2026-10-01 0001402328 7 2026-10-01 2026-10-01 0001402328 2026-10-01 2026-10-01 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-1

Sunshine Biopharma Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common Units, each consisting of: (i) one share of common stock, 0.001 par value per share (Common Stock) and (ii) two Series D Warrants to purchase shares of Common Stock   (1)   457(o)       $     $ 7,000,000.00   0.000087   $ 609.00
Fees to be Paid   Equity   Common Stock included as part of the Common Units   (2)   457(o)               0.00   0.000087     0.00
Fees to be Paid   Other   Pre-Funded Units, each consisting of: (i) one Pre-Funded Warrant exercisable for one share of Common Stock; and (ii) two Series D Warrants   (3)   457(o)               0.00   0.000087     0.00
Fees to be Paid   Other   Pre-Funded Warrants to purchase Common Stock, included as part of the Pre-Funded Units   (4)   Other               0.00   0.000087     0.00
Fees to be Paid   Equity   Common Stock underlying Pre-Funded Warrants   (5)   457(o)               0.00   0.000087     0.00
Fees to be Paid   Other   Series D Warrants to Purchase Common Stock, included as part of the Common Units and Pre-Funded Units   (6)   Other               0.00   0.000087     0.00
Fees to be Paid   Equity   Common Stock underlying Series D Warrants   (7)   457(o)       $     $ 14,000,000.00   0.000087   $ 1,218.00
                                           
Total Offering Amounts:   $ 21,000,000.00         1,827.00
Total Fees Previously Paid:                
Total Fee Offsets:               0.00
Net Fee Due:             $ 1,827.00

__________________________________________
Offering Note(s)

(1) Estimated solely for the purpose of calculating the amount of the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the "Securities Act"). Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant's securities that become issuable by reason of any share splits, share dividends or similar transactions.
(2) See footnote 1
(3) The proposed maximum aggregate offering price of Common Units proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Units sold in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Units to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Units sold in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Units and Pre-Funded Units is $7,000,000.
(4) No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.
(5) See footnote 1
(6) See footnote 1
(7) The exercise price of each Series D Warrant is equal to the offering price per Common Unit.